Skip to content
10-Q

Quarterly Report

CIDARA THERAPEUTICS, INC.

0001610618-25-000096

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 31.44M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.88M sh
Shares Diluted Q3 2025 · Sep 30, 2025 18.92M sh
Shares Diluted Q3 2025 · Sep 30, 2024 6.53M sh
Shares Diluted Q3 2025 · Sep 30, 2024 5.22M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $129K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$103.53M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$147.12M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $293.65M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $189.83M
Stockholders Equity Q3 2025 · Sep 30, 2025 $422.39M
Stockholders Equity Q3 2025 · Jun 30, 2025 $501.17M
Stockholders Equity Q3 2025 · Mar 31, 2025 $141.68M
Stockholders Equity Q3 2025 · Dec 31, 2024 $163.31M
Stockholders Equity Q3 2025 · Sep 30, 2024 $115.63M
Stockholders Equity Q3 2025 · Jun 30, 2024 $130.94M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$17.78M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$8.21M
Current Liabilities Q3 2025 · Sep 30, 2025 $95.84M
Current Liabilities Q3 2025 · Dec 31, 2024 $49.55M
Total Liabilities Q3 2025 · Sep 30, 2025 $96.26M
Total Liabilities Q3 2025 · Dec 31, 2024 $51.49M
Current Assets Q3 2025 · Sep 30, 2025 $442.82M
Current Assets Q3 2025 · Dec 31, 2024 $210.74M
Total Assets Q3 2025 · Sep 30, 2025 $518.65M
Total Assets Q3 2025 · Dec 31, 2024 $214.8M
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.10
Eps Diluted Q3 2025 · Sep 30, 2025 −$7.00
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.45
Eps Diluted Q3 2025 · Sep 30, 2024 −$22.53
Eps Basic Q3 2025 · Sep 30, 2025 −$3.10
Eps Basic Q3 2025 · Sep 30, 2025 −$7.00
Eps Basic Q3 2025 · Sep 30, 2024 −$2.45
Eps Basic Q3 2025 · Sep 30, 2024 −$22.53
Sga Expense Q3 2025 · Sep 30, 2025 $8.1M
Sga Expense Q3 2025 · Sep 30, 2025 $20.78M
Sga Expense Q3 2025 · Sep 30, 2024 $4.97M
Sga Expense Q3 2025 · Sep 30, 2024 $13.31M
Rd Expense Q3 2025 · Sep 30, 2025 $35.53M
Rd Expense Q3 2025 · Sep 30, 2025 $84.95M
Rd Expense Q3 2025 · Sep 30, 2024 $12.43M
Rd Expense Q3 2025 · Sep 30, 2024 $25.01M
Net Income Q3 2025 · Sep 30, 2025 −$83.23M
Net Income Q3 2025 · Sep 30, 2025 −$132.43M
Net Income Q3 2025 · Jun 30, 2025 −$25.72M
Net Income Q3 2025 · Mar 31, 2025 −$23.48M
Net Income Q3 2025 · Sep 30, 2024 −$15.99M
Net Income Q3 2025 · Sep 30, 2024 −$117.52M
Net Income Q3 2025 · Jun 30, 2024 −$91.21M
Net Income Q3 2025 · Mar 31, 2024 −$10.33M
Operating Income Q3 2025 · Sep 30, 2025 −$88.63M
Operating Income Q3 2025 · Sep 30, 2025 −$141.28M
Operating Income Q3 2025 · Sep 30, 2024 −$17.39M
Operating Income Q3 2025 · Sep 30, 2024 −$121.92M